ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
97 hedge funds and large institutions have $171M invested in Antares Pharma, Inc. in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 47 increasing their positions, 18 reducing their positions, and 4 closing their positions.
Holders
97
Holders Change
+10
Holders Change %
+11.49%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
47
Reduced
18
Closed
4
Calls
$1.01M
Puts
$368K
Net Calls
+$640K
Net Calls Change
+$2.16M
Top Buyers
Top Sellers
1 |
O
1
OrbiMed
New York
|
$17.7M |
2 |
DM
2
Deerfield Management
New York
|
$35.1M |
3 |
![]()
3
Fidelity Investments
Boston,
Massachusetts
|
$1.99M |
4 |
UOC
4
UBS O'Connor
Chicago,
Illinois
|
$1.08M |
5 |
TCIM
5
TIAA CREF Investment Management
New York
|
$1.85M |